Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ADMA Biologics Inc

ADMA
Current price
16.66 USD -0.07 USD (-0.42%)
Last closed 16.87 USD
ISIN US0008991046
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 4 486 682 112 USD
Yield for 12 month +205.13 %
1Y
3Y
5Y
10Y
15Y
ADMA
21.11.2021 - 28.11.2021

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Address: 465 State Route 17, Ramsey, NJ, United States, 07446

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

23.45 USD

P/E ratio

70.30

Dividend Yield

Current Year

+258 214 999 USD

Last Year

+154 079 692 USD

Current Quarter

+119 839 000 USD

Last Quarter

+107 191 000 USD

Current Year

+88 941 999 USD

Last Year

+35 265 157 USD

Current Quarter

+59 659 000 USD

Last Quarter

+57 311 000 USD

Key Figures ADMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 125 894 000 USD
Operating Margin TTM 33.08 %
PE Ratio 70.30
Return On Assets TTM 19.89 %
PEG Ratio
Return On Equity TTM 35.55 %
Wall Street Target Price 23.45 USD
Revenue TTM 382 808 992 USD
Book Value 0.98 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 78.10 %
Dividend Yield
Gross Profit TTM 35 265 157 USD
Earnings per share 0.27 USD
Diluted Eps TTM 0.27 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 1 400.00 %
Profit Margin 17.80 %

Dividend Analytics ADMA

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History ADMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ADMA

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 70.30
Forward PE 21.14
Enterprise Value Revenue 11.54
Price Sales TTM 11.72
Enterprise Value EBITDA 44.71
Price Book MRQ 18.95

Financials ADMA

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ADMA

For 52 weeks

4.06 USD 23.64 USD
50 Day MA 18.99 USD
Shares Short Prior Month 14 239 500
200 Day MA 13.28 USD
Short Ratio 3.47
Shares Short 12 906 077
Short Percent 5.62 %